Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry

Joan Sweeney; Chris E Brightling; Andrew Menzies-Gow; Robert Niven; Chris C Patterson; Liam G Heaney

doi:10.1136/thoraxjnl-2012-201869

Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry

Joan Sweeney, Chris E Brightling, Andrew Menzies-Gow, Robert Niven, Chris C Patterson, Liam G Heaney

Research output: Contribution to journal › Article › peer-review

68 Citations (Scopus)

317 Downloads (Pure)

Abstract

Refractory asthma represents a significant unmet clinical need. Data from a national online registry audited clinical outcome in 349 adults with refractory asthma from four UK specialist centres in the British Thoracic Society Difficult Asthma Network. At follow-up, lung function improved, with a reduction in important healthcare outcomes, specifically hospital admission, unscheduled healthcare visits and rescue courses of oral steroids. The most frequent therapeutic intervention was maintenance oral corticosteroids and most steroid sparing agents (apart from omalizumab) demonstrated minimal steroid sparing benefit. A significant unmet clinical need remains in this group, specifically a requirement for therapies which reduce systemic steroid exposure.

Original language	English
Pages (from-to)	754-756
Number of pages	3
Journal	Thorax
Volume	67
Issue number	8
Early online date	11 May 2012
DOIs	https://doi.org/10.1136/thoraxjnl-2012-201869
Publication status	Published - Aug 2012

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1136/thoraxjnl-2012-201869

Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Asthma Network
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
Final published version, 99.4 KB

Improvements in clinical assessment and management of Difficult-to-treat Asthma in Adults
Liam Heaney (Participant), Michael Stevenson (Participant), Diarmuid McNicholl (Participant), Lorcan McGarvey (Participant), Joan Sweeney (Participant) & Christopher Patterson (Participant)
Impact: Health Impact, Quality of Life Impact

Cite this

@article{c4f0c98a5cd041ffb18e94882f79253b,

title = "Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry",

abstract = "Refractory asthma represents a significant unmet clinical need. Data from a national online registry audited clinical outcome in 349 adults with refractory asthma from four UK specialist centres in the British Thoracic Society Difficult Asthma Network. At follow-up, lung function improved, with a reduction in important healthcare outcomes, specifically hospital admission, unscheduled healthcare visits and rescue courses of oral steroids. The most frequent therapeutic intervention was maintenance oral corticosteroids and most steroid sparing agents (apart from omalizumab) demonstrated minimal steroid sparing benefit. A significant unmet clinical need remains in this group, specifically a requirement for therapies which reduce systemic steroid exposure.",

author = "Joan Sweeney and Brightling, {Chris E} and Andrew Menzies-Gow and Robert Niven and Patterson, {Chris C} and Heaney, {Liam G}",

year = "2012",

month = aug,

doi = "10.1136/thoraxjnl-2012-201869",

language = "English",

volume = "67",

pages = "754--756",

journal = "Thorax",

issn = "0040-6376",

publisher = "BMJ Publishing Group",

number = "8",

}

TY - JOUR

T1 - Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry

AU - Sweeney, Joan

AU - Brightling, Chris E

AU - Menzies-Gow, Andrew

AU - Niven, Robert

AU - Patterson, Chris C

AU - Heaney, Liam G

PY - 2012/8

Y1 - 2012/8

N2 - Refractory asthma represents a significant unmet clinical need. Data from a national online registry audited clinical outcome in 349 adults with refractory asthma from four UK specialist centres in the British Thoracic Society Difficult Asthma Network. At follow-up, lung function improved, with a reduction in important healthcare outcomes, specifically hospital admission, unscheduled healthcare visits and rescue courses of oral steroids. The most frequent therapeutic intervention was maintenance oral corticosteroids and most steroid sparing agents (apart from omalizumab) demonstrated minimal steroid sparing benefit. A significant unmet clinical need remains in this group, specifically a requirement for therapies which reduce systemic steroid exposure.

AB - Refractory asthma represents a significant unmet clinical need. Data from a national online registry audited clinical outcome in 349 adults with refractory asthma from four UK specialist centres in the British Thoracic Society Difficult Asthma Network. At follow-up, lung function improved, with a reduction in important healthcare outcomes, specifically hospital admission, unscheduled healthcare visits and rescue courses of oral steroids. The most frequent therapeutic intervention was maintenance oral corticosteroids and most steroid sparing agents (apart from omalizumab) demonstrated minimal steroid sparing benefit. A significant unmet clinical need remains in this group, specifically a requirement for therapies which reduce systemic steroid exposure.

U2 - 10.1136/thoraxjnl-2012-201869

DO - 10.1136/thoraxjnl-2012-201869

M3 - Article

C2 - 22581823

VL - 67

SP - 754

EP - 756

JO - Thorax

JF - Thorax

SN - 0040-6376

IS - 8

ER -

Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry

Abstract

ASJC Scopus subject areas

Access to Document

Fingerprint

Impacts

Improvements in clinical assessment and management of Difficult-to-treat Asthma in Adults

Cite this